Human Mesenchymal Stem Cells Increase Anti-oxidant Defences in Cells Derived from Patients with Friedreich’s Ataxia (original) (raw)

• Alper G, Narayanan V. Friedreich’s ataxia. Pediatr Neurol. 2003;28:335–41.
  Article PubMed Google Scholar
• Durr A. Friedreich’s ataxia: treatment within reach. Lancet Neurol. 2002;1:370–4.
  Article PubMed Google Scholar
• Pandolfo M. Friedreich ataxia: the clinical picture. J Neurol. 2009;256 Suppl 1:3–8.
  Article PubMed Google Scholar
• Rufini A, Fortuni S, Arcuri G, Condo I, Serio D, Incani O, et al. Preventing the ubiquitin–proteasome-dependent degradation of frataxin, the protein defective in Friedreich’s ataxia. Hum Mol Genet. 2011;20:1253–61.
  Article PubMed CAS Google Scholar
• Pandolfo M, Pastore A. The pathogenesis of Friedreich ataxia and the structure and function of frataxin. J Neurol. 2009;256 Suppl 1:9–17.
  Article PubMed CAS Google Scholar
• Calabrese V, Lodi R, Tonon C, D’Agata V, Sapienza M, Scapagnini G, et al. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich’s ataxia. J Neurol Sci. 2005;233:145–62.
  Article PubMed CAS Google Scholar
• Koeppen AH, Davis AN, Morral JA. The cerebellar component of Friedreich’s ataxia. Acta Neuropathol. 2011;122:323–30.
  Article PubMed Google Scholar
• Cavadini P, O’Neill HA, Benada O, Isaya G. Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia. Hum Mol Genet. 2002;11:217–27.
  Article PubMed CAS Google Scholar
• Santos R, Lefevre S, Sliwa D, Seguin A, Camadro JM, Lesuisse E. Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities. Antioxid Redox Signal. 2010;13:651–90.
  Article PubMed CAS Google Scholar
• Hausse AO, Aggoun Y, Bonnet D, Sidi D, Munnich A, Rotig A, et al. Idebenone and reduced cardiac hypertrophy in Friedreich’s ataxia. Heart. 2002;87:346–9.
  Article PubMed CAS Google Scholar
• Kemp K, Mallam E, Hares K, Witherick J, Scolding N, Wilkins A. Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblasts. PLoS One. 2011;6:e26098.
  Article PubMed CAS Google Scholar
• Kemp K, Gordon D, Wraith DC, Mallam E, Hartfield E, Uney J, et al. Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells. Neuropathol Appl Neurobiol 2010;37:166–78.
  Google Scholar
• Kemp K, Gray E, Mallam E, Scolding N, Wilkins A. Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells. Stem Cell Rev 2010;6:548–59.
  Google Scholar
• Mallam E, Kemp K, Wilkins A, Rice C, Scolding N. Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis. Mult Scler 2010;16:909–18.
  Google Scholar
• Wilkins A, Kemp K, Ginty M, Hares K, Mallam E, Scolding N. Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res 2009;3:63–70.
  Google Scholar
• Kemp K, Hares K, Mallam E, Heesom KJ, Scolding N, Wilkins A. Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival. J Neurochem. 2010;114:1569–80.
  Article PubMed CAS Google Scholar
• Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 2002;33:337–49.
  Article PubMed CAS Google Scholar
• Wilkins A, Compston A. Trophic factors attenuate nitric oxide mediated neuronal and axonal injury in vitro: roles and interactions of mitogen-activated protein kinase signalling pathways. J Neurochem. 2005;92:1487–96.
  Article PubMed CAS Google Scholar
• Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S, et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet. 1997;6:1771–80.
  Article PubMed CAS Google Scholar
• Koeppen AH. Friedreich’s ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci. 2011;303:1–12.
  Article PubMed CAS Google Scholar
• Pianese L, Turano M, Lo Casale MS, De Biase I, Giacchetti M, Monticelli A, et al. Real time PCR quantification of frataxin mRNA in the peripheral blood leucocytes of Friedreich ataxia patients and carriers. J Neurol Neurosurg Psychiatry. 2004;75:1061–3.
  Article PubMed CAS Google Scholar
• Acquaviva F, Castaldo I, Filla A, Giacchetti M, Marmolino D, Monticelli A, et al. Recombinant human erythropoietin increases frataxin protein expression without increasing mRNA expression. Cerebellum. 2008;7:360–5.
  Article PubMed CAS Google Scholar
• Herman D, Jenssen K, Burnett R, Soragni E, Perlman SL, Gottesfeld JM. Histone deacetylase inhibitors reverse gene silencing in Friedreich’s ataxia. Nat Chem Biol. 2006;2:551–8.
  Article PubMed CAS Google Scholar
• Pook MA, Al-Mahdawi S, Carroll CJ, Cossee M, Puccio H, Lawrence L, et al. Rescue of the Friedreich’s ataxia knockout mouse by human YAC transgenesis. Neurogenetics. 2001;3:185–93.
  PubMed CAS Google Scholar
• Kontoghiorghes GJ. Prospects for introducing deferiprone as potent pharmaceutical antioxidant. Front Biosci (Elite Ed). 2009;1:161–78.
  Google Scholar
• Velasco-Sanchez D, Aracil A, Montero R, Mas A, Jimenez L, O’Callaghan M, et al. Combined therapy with idebenone and deferiprone in patients with Friedreich’s ataxia. Cerebellum. 2011;10:1–8.
  Article PubMed CAS Google Scholar
• Sparaco M, Gaeta LM, Santorelli FM, Passarelli C, Tozzi G, Bertini E, et al. Friedreich’s ataxia: oxidative stress and cytoskeletal abnormalities. J Neurol Sci. 2009;287:111–8.
  Article PubMed CAS Google Scholar
• Busi MV, Gomez-Casati DF. Exploring frataxin function. IUBMB Life 2012;64:56–63.
• Armstrong JS, Khdour O, Hecht SM. Does oxidative stress contribute to the pathology of Friedreich’s ataxia? A radical question. FASEB J. 2010;24:2152–63.
  Article PubMed CAS Google Scholar
• Michiels C, Raes M, Toussaint O, Remacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med. 1994;17:235–48.
  Article PubMed CAS Google Scholar
• Esposito LA, Kokoszka JE, Waymire KG, Cottrell B, MacGregor GR, Wallace DC. Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene. Free Radic Biol Med. 2000;28:754–66.
  Article PubMed CAS Google Scholar
• Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87:1620–4.
  Article PubMed CAS Google Scholar
• Schulz JB, Dehmer T, Schols L, Mende H, Hardt C, Vorgerd M, et al. Oxidative stress in patients with Friedreich ataxia. Neurology. 2000;55:1719–21.
  Article PubMed CAS Google Scholar
• Garcia-Gimenez JL, Gimeno A, Gonzalez-Cabo P, Dasi F, Bolinches-Amoros A, Molla B, et al. Differential expression of PGC-1alpha and metabolic sensors suggest age-dependent induction of mitochondrial biogenesis in Friedreich ataxia fibroblasts. PLoS One. 2011;6:e20666.
  Article PubMed CAS Google Scholar
• Chantrel-Groussard K, Geromel V, Puccio H, Koenig M, Munnich A, Rotig A, et al. Disabled early recruitment of antioxidant defenses in Friedreich’s ataxia. Hum Mol Genet. 2001;10:2061–7.
  Article PubMed CAS Google Scholar
• Seznec H, Simon D, Bouton C, Reutenauer L, Hertzog A, Golik P, et al. Friedreich ataxia: the oxidative stress paradox. Hum Mol Genet. 2005;14:463–74.
  Article PubMed CAS Google Scholar
• Irazusta V, Obis E, Moreno-Cermeno A, Cabiscol E, Ros J, Tamarit J. Yeast frataxin mutants display decreased superoxide dismutase activity crucial to promote protein oxidative damage. Free Radic Biol Med. 2010;48:411–20.
  Article PubMed CAS Google Scholar
• Paupe V, Dassa EP, Goncalves S, Auchere F, Lonn M, Holmgren A, et al. Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia. PLoS One. 2009;4:e4253.
  Article PubMed Google Scholar
• Irazusta V, Cabiscol E, Reverter-Branchat G, Ros J, Tamarit J. Manganese is the link between frataxin and iron-sulfur deficiency in the yeast model of Friedreich ataxia. J Biol Chem. 2006;281:12227–32.
  Article PubMed CAS Google Scholar
• Foury F, Cazzalini O. Deletion of the yeast homologue of the human gene associated with Friedreich’s ataxia elicits iron accumulation in mitochondria. FEBS Lett. 1997;411:373–7.
  Article PubMed CAS Google Scholar
• Wong A, Yang J, Cavadini P, Gellera C, Lonnerdal B, Taroni F, et al. The Friedreich’s ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet. 1999;8:425–30.
  Article PubMed CAS Google Scholar
• Finocchietto PV, Franco MC, Holod S, Gonzalez AS, Converso DP, Antico Arciuch VG, et al. Mitochondrial nitric oxide synthase: a masterpiece of metabolic adaptation, cell growth, transformation, and death. Exp Biol Med (Maywood). 2009;234:1020–8.
  Article CAS Google Scholar
• Bayot A, Santos R, Camadro JM, Rustin P. Friedreich’s ataxia: the vicious circle hypothesis revisited. BMC Med. 2011;9:112.
  Article PubMed CAS Google Scholar
• Napoli E, Taroni F, Cortopassi GA. Frataxin, iron–sulfur clusters, heme, ROS, and aging. Antioxid Redox Signal. 2006;8:506–16.
  Article PubMed CAS Google Scholar
• Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol. 2000;10:381–91.
  Article PubMed CAS Google Scholar
• Goldberg JL, Barres BA. The relationship between neuronal survival and regeneration. Annu Rev Neurosci. 2000;23:579–612.
  Article PubMed CAS Google Scholar
• Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med. 2005;9:59–71.
  Article PubMed CAS Google Scholar
• Klesse LJ, Parada LF. p21 ras and phosphatidylinositol-3 kinase are required for survival of wild-type and NF1 mutant sensory neurons. J Neurosci. 1998;18:10420–8.
  PubMed CAS Google Scholar
• Diem R, Meyer R, Weishaupt JH, Bahr M. Reduction of potassium currents and phosphatidylinositol 3-kinase-dependent AKT phosphorylation by tumor necrosis factor-(alpha) rescues axotomized retinal ganglion cells from retrograde cell death in vivo. J Neurosci. 2001;21:2058–66.
  PubMed CAS Google Scholar
• Encinas M, Tansey MG, Tsui-Pierchala BA, Comella JX, Milbrandt J, Johnson Jr EM. c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a phosphatidylinositol-3 kinase (PI-3K)-dependent pathway. J Neurosci. 2001;21:1464–72.
  PubMed CAS Google Scholar
• Crowder RJ, Freeman RS. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J Neurosci. 1998;18:2933–43.
  PubMed CAS Google Scholar
• Vaillant AR, Mazzoni I, Tudan C, Boudreau M, Kaplan DR, Miller FD. Depolarization and neurotrophins converge on the phosphatidylinositol 3-kinase-Akt pathway to synergistically regulate neuronal survival. J Cell Biol. 1999;146:955–66.
  Article PubMed CAS Google Scholar
• Asada S, Daitoku H, Matsuzaki H, Saito T, Sudo T, Mukai H, et al. Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell Signal. 2007;19:519–27.
  Article PubMed CAS Google Scholar
• Chen RW, Lu XC, Yao C, Liao Z, Jiang ZG, Wei H, et al. PAN-811 provides neuroprotection against glutamate toxicity by suppressing activation of JNK and p38 MAPK. Neurosci Lett. 2007;422:64–7.
  Article PubMed CAS Google Scholar
• Yamagishi S, Matsumoto T, Yokomaku D, Hatanaka H, Shimoke K, Yamada M, et al. Comparison of inhibitory effects of brain-derived neurotrophic factor and insulin-like growth factor on low potassium-induced apoptosis and activation of p38 MAPK and c-Jun in cultured cerebellar granule neurons. Brain Res Mol Brain Res. 2003;119:184–91.
  Article PubMed CAS Google Scholar
• Pandolfo M. Frataxin deficiency and mitochondrial dysfunction. Mitochondrion. 2002;2:87–93.
  Article PubMed CAS Google Scholar